BriefScience

Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug

·2h ago
Share:PostShare
R

Reuters

Original source

Read full story

Related Stories

Science2h ago

Zydus, Formycon move to front of Keytruda biosimilar race

The U.S. FDA accepted Zydus Lifesciences Ltd. and Formycon AG’s BLA for FYB-206, a proposed biosimilar to Keytruda (pembrolizumab), putting the partners among the frontrunners pursuing a share of the $30 billion-plus oncology market commanded by Merck & Co. Inc.’s blockbuster drug.

BBioworld
Science14h ago

Digital heritage opens new avenues for cultural preservation, public access

The Southern Women’s Museum has so far digitised 1,113 artefacts, but only 113 are currently accessible to the public. According to deputy director of the museum Pham Thi Dieu, thousands of other artefacts are awaiting an exhibition system under an expansion project. The museum hopes to complete the system in 2027, enabling online visitors to explore the digitised collections. Bat Trang pottery village preserves heritage in digital age Virtual museums bring Lam Dong's heritage into digital age Digital transformation in heritage should adopt people-centred approach: UNESCO

VVietnam+

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer